Article ID Journal Published Year Pages File Type
4231604 Journal of the American College of Radiology 2011 6 Pages PDF
Abstract
The broadening of imaging capabilities and the increasing capacity of imaging to quantitate biologic processes has increased industry interest in using imaging methods in new drug development. Investigators participating in industry-sponsored trials should be aware of how such trials differ from investigator-initiated, grant-funded research. In particular, investigators should be cognizant of possible ethical conflicts in the care of patients, the development and analysis of data, and issues related to the dissemination of results.
Related Topics
Health Sciences Medicine and Dentistry Radiology and Imaging
Authors
, , ,